Advertisement

CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard

  • Jieun Byun
  • Seung Soo LeeEmail author
  • Yu Sub Sung
  • Youngbin Shin
  • Jessica Yun
  • Ho Sung Kim
  • Eun sil Yu
  • Sung-Gyu Lee
  • Moon-gyu Lee
Gastrointestinal
  • 64 Downloads

Abstract

Objectives

To compare the performances of CT indices for diagnosing hepatic steatosis (HS) and to determine and validate the CT index cut-off values.

Methods

Three indices were measured on non-enhanced CT images of 4413 living liver donor candidates (2939 men, 1474 women; mean age, 31.4 years): hepatic attenuation (CTL), hepatic attenuation minus splenic attenuation (CTL-S), and hepatic attenuation divided by splenic attenuation (CTL/S). The performances of these CT indices in diagnosing HS, relative to pathologic diagnosis, were compared in the development cohort of 3312 subjects by receiver operating characteristic (ROC) analysis. The cut-off values for diagnosing HS > 33% in the development cohort were determined at 95% specificity and 95% sensitivity using bootstrap ROC analysis, and the diagnostic performance of these cut-off values was validated in the test cohort of 1101 subjects.

Results

CTL-S showed the highest performance for diagnosing HS ≥ 5% and HS > 33% (areas under the curve (AUCs) = 0.737 and 0.926, respectively), followed by CTL/S (AUCs = 0.732 and 0.925, respectively) and CTL (AUCs = 0.707 and 0.880, respectively). For CT scans using 120 kVp, the CTL-S cut-off values for highly specific (i.e., − 2.1) and highly sensitive (i.e., 7.6) diagnosis of HS > 33% resulted in a specificity of 96.4% with a sensitivity of 64.0% and a sensitivity of 97.3% with a specificity of 54.9%, respectively, in the test cohort.

Conclusion

CT indices using liver and spleen attenuations have higher performance for diagnosing HS than indices using liver attenuation alone. The CTL-S cut-off values in this study may have utility for diagnosing HS in clinical practice and research.

Key Points

CT indices based on both liver attenuation and spleen attenuation (CTL-S and CTL/S) have higher diagnostic performance than CTL based on liver attenuation alone in diagnosing HS using various CT techniques.

The CT index cut-off values determined in this study can be utilized for reliable diagnosis or to rule out subjects with moderate to severe HS in clinical practice and research, including the selection of living liver donors and the development of cohorts with HS or healthy controls.

Keywords

Fatty liver Non-alcoholic fatty liver disease Tomography, X-ray computed 

Abbreviations

AUROC

Areas under the receiver operating characteristic curve

CI

Confidence interval

CT

Computed tomography

CTL

Hepatic attenuation

CTL-S

Hepatic attenuation minus splenic attenuation

CTL/S

Hepatic attenuation divided by splenic attenuation

HS

Hepatic steatosis

NAFLD

Non-alcoholic fatty liver disease

ROC

Receiver operating characteristic

ROI

Region of interest

Notes

Funding

This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (NRF-2017R1A2B4003114), the Bio and Medical Technology Development Program of the NRF funded by the Ministry of Science and ICT (NRF-2016M3A9A7918706), a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI18C2383), and a grant (2014-444) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.

Compliance with ethical standards

Guarantor

The scientific guarantor of this publication is Seung Soo Lee.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

One of the authors has significant statistical expertise.

Informed consent

Written informed consent was waived by the institutional review board.

Ethical approval

Institutional review board approval was obtained.

Methodology

• retrospective

• diagnostic or prognostic study

• performed at one institution

Supplementary material

330_2018_5905_MOESM1_ESM.docx (1.2 mb)
ESM 1 (DOCX 1258 kb)

References

  1. 1.
    Teli MR, James OF, Burt AD, Bennett MK, Day CP (1995) The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22:1714–1719CrossRefGoogle Scholar
  2. 2.
    de Alwis NM, Day CP (2008) Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 48(Suppl 1):S104–S112CrossRefGoogle Scholar
  3. 3.
    Adams LA, Sanderson S, Lindor KD, Angulo P (2005) The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 42:132–138CrossRefGoogle Scholar
  4. 4.
    Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN (2010) The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51:1972–1978CrossRefGoogle Scholar
  5. 5.
    Korenblat KM, Fabbrini E, Mohammed BS, Klein S (2008) Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 134:1369–1375CrossRefGoogle Scholar
  6. 6.
    Gastaldelli A, Kozakova M, Højlund K et al (2009) Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 49:1537–1544CrossRefGoogle Scholar
  7. 7.
    Marsman WA, Wiesner RH, Rodriguez L et al (1996) Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 62:1246–1251CrossRefGoogle Scholar
  8. 8.
    Takyar V, Nath A, Beri A, Gharib AM, Rotman Y (2017) How healthy are the “healthy volunteers”? Penetrance of NAFLD in the biomedical research volunteer pool. Hepatology 66:825–833CrossRefGoogle Scholar
  9. 9.
    Lee SS, Park SH (2014) Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol 20:7392–7402CrossRefGoogle Scholar
  10. 10.
    Lee SS, Park SH, Kim HJ et al (2010) Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 52:579–585CrossRefGoogle Scholar
  11. 11.
    Boyce CJ, Pickhardt PJ, Kim DH et al (2010) Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 194:623–628CrossRefGoogle Scholar
  12. 12.
    Hahn L, Reeder SB, Muñoz del Rio A, Pickhardt PJ (2015) Longitudinal changes in liver fat content in asymptomatic adults: hepatic attenuation on unenhanced CT as an imaging biomarker for steatosis. AJR Am J Roentgenol 205:1167–1172CrossRefGoogle Scholar
  13. 13.
    Iwasaki M, Takada Y, Hayashi M et al (2004) Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 78:1501–1505CrossRefGoogle Scholar
  14. 14.
    Kan H, Kimura Y, Hyogo H et al (2014) Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease. Hepatol Res 44:E420–E427CrossRefGoogle Scholar
  15. 15.
    Limanond P, Raman SS, Lassman C et al (2004) Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230:276–280CrossRefGoogle Scholar
  16. 16.
    Park SH, Kim PN, Kim KW et al (2006) Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 239:105–112CrossRefGoogle Scholar
  17. 17.
    Park YS, Park SH, Lee SS et al (2011) Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT. Radiology 258:760–766CrossRefGoogle Scholar
  18. 18.
    Pickhardt PJ, Park SH, Hahn L, Lee SG, Bae KT, Yu ES (2012) Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. Eur Radiol 22:1075–1082CrossRefGoogle Scholar
  19. 19.
    Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA (1980) Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 137:727–729CrossRefGoogle Scholar
  20. 20.
    Rogier J, Roullet S, Cornélis F et al (2015) Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver-to-spleen attenuation ratio. Liver Transpl 21:690–695CrossRefGoogle Scholar
  21. 21.
    Mellinger JL, Pencina KM, Massaro JM et al (2015) Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham Heart Study. J Hepatol 63:470–476CrossRefGoogle Scholar
  22. 22.
    Pickhardt PJ, Hahn L, Muñoz del Rio A, Park SH, Reeder SB, Said A (2014) Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications. AJR Am J Roentgenol 202:752–758CrossRefGoogle Scholar
  23. 23.
    Hong HC, Hwang SY, Choi HY et al (2014) Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology 59:1772–1778CrossRefGoogle Scholar
  24. 24.
    Puchner SB, Lu MT, Mayrhofer T et al (2015) High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial. Radiology 274:693–701CrossRefGoogle Scholar
  25. 25.
    Bae JC, Lee WY, Yoon KH et al (2015) Improvement of nonalcoholic fatty liver disease with Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): a randomized controlled trial. Diabetes Care 38:1245–1252CrossRefGoogle Scholar
  26. 26.
    Bos D, Leening MJG (2018) Leveraging the coronary calcium scan beyond the coronary calcium score. Eur Radiol 28:3082–3087CrossRefGoogle Scholar
  27. 27.
    Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRefGoogle Scholar
  28. 28.
    DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefGoogle Scholar
  29. 29.
    Kodama Y, Ng CS, Wu TT et al (2007) Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 188:1307–1312CrossRefGoogle Scholar
  30. 30.
    Kaul A, Bauer B, Bernhardt J, Nosske D, Veit R (1997) Effective doses to members of the public from the diagnostic application of ionizing radiation in Germany. Eur Radiol 7:1127–1132CrossRefGoogle Scholar
  31. 31.
    Nakayama Y, Awai K, Funama Y et al (2005) Abdominal CT with low tube voltage: preliminary observations about radiation dose, contrast enhancement, image quality, and noise. Radiology 237:945–951CrossRefGoogle Scholar
  32. 32.
    Tran TT, Changsri C, Shackleton CR et al (2006) Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors. J Gastroenterol Hepatol 21:381–383CrossRefGoogle Scholar

Copyright information

© European Society of Radiology 2018

Authors and Affiliations

  • Jieun Byun
    • 1
  • Seung Soo Lee
    • 1
    Email author
  • Yu Sub Sung
    • 1
  • Youngbin Shin
    • 1
  • Jessica Yun
    • 1
  • Ho Sung Kim
    • 1
  • Eun sil Yu
    • 2
  • Sung-Gyu Lee
    • 3
  • Moon-gyu Lee
    • 1
  1. 1.Department of Radiology and Research Institute of Radiology, Asan Medical CenterUniversity of Ulsan College of MedicineSeoulSouth Korea
  2. 2.Department of Diagnostic Pathology, Asan Medical CenterUniversity of Ulsan College of MedicineSeoulSouth Korea
  3. 3.Division of Hepatobiliary Surgery and Liver Transplantation, Department of SurgeryUniversity of Ulsan College of MedicineSeoulSouth Korea

Personalised recommendations